Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Today’s headlines highlight critical developments in genetic medicine, global politics, and the latest updates from the ...

Another exciting area of personalized medicine is using nanotechnology for gene therapy. Gene therapy involves altering or ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...